FindTrial
Sign In

TOPIC LEVETIRACETAM IN ANAL FISSURE. A PILOT STUDY ABOUT EFFECTIVENESS AND TOLERABLENESS - ND

TOPIC LEVETIRACETAM IN ANAL FISSURE. A PILOT STUDY ABOUT EFFECTIVENESS AND TOLERABLENESS - ND

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2007-004114-13-IT
Enrollment
Unknown
Registered
2007-12-12
Start date
2008-01-07
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anal fissure MedDRA version: 9.1 Level: LLT Classification code 10002153 Term: Anal fissure

Interventions

Product Name: Levetiracetam Pharmaceutical Form: Cream INN or Proposed INN: Levetiracetam Concentration unit: % percent Concentration type: equal Concentration number: .2-

Sponsors

POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients, males and females, affected by anal fissure Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Age 75, pregnancy, others diseases, blood disorders, psychiatrical therapy, myasthenia, levetiracetam hypersensitivity

Design outcomes

Primary

MeasureTime frame
Main Objective: To investigate therapeutical capabilites of topical application of levetiracetam in anal fissure;Secondary Objective: To investigate levetiracetam?s action on pain, tolerableness and reduction of tone of internal anal sphincter muscle;Primary end point(s): Therapy of anal fissure—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026